Publication | Open Access
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
608
Citations
42
References
2019
Year
OncologyMedicinePotent Antitumor ActivityImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1